ATE540693T1 - Impfung und impfstoffe gegen hundeherpesvirus - Google Patents
Impfung und impfstoffe gegen hundeherpesvirusInfo
- Publication number
- ATE540693T1 ATE540693T1 AT01905858T AT01905858T ATE540693T1 AT E540693 T1 ATE540693 T1 AT E540693T1 AT 01905858 T AT01905858 T AT 01905858T AT 01905858 T AT01905858 T AT 01905858T AT E540693 T1 ATE540693 T1 AT E540693T1
- Authority
- AT
- Austria
- Prior art keywords
- chv
- against canine
- vaccination
- canine herpesvirus
- pregnant
- Prior art date
Links
- 241000680578 Canid alphaherpesvirus 1 Species 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 238000002255 vaccination Methods 0.000 title 1
- 208000029433 Herpesviridae infectious disease Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16761—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0000797A FR2804026B1 (fr) | 2000-01-21 | 2000-01-21 | Vaccination contre l'herpesvirose canine et vaccins |
| PCT/FR2001/000189 WO2001052887A2 (fr) | 2000-01-21 | 2001-01-19 | Vaccination contre l"herpesvirose canine et vaccins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE540693T1 true ATE540693T1 (de) | 2012-01-15 |
Family
ID=8846182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01905858T ATE540693T1 (de) | 2000-01-21 | 2001-01-19 | Impfung und impfstoffe gegen hundeherpesvirus |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1248648B1 (de) |
| JP (1) | JP2003520249A (de) |
| AT (1) | ATE540693T1 (de) |
| AU (1) | AU782657C (de) |
| BR (2) | BRPI0107771B1 (de) |
| CA (1) | CA2397861C (de) |
| FR (1) | FR2804026B1 (de) |
| HU (1) | HU228703B1 (de) |
| MX (1) | MXPA02007115A (de) |
| NZ (1) | NZ520242A (de) |
| PL (1) | PL209070B1 (de) |
| WO (1) | WO2001052887A2 (de) |
| ZA (1) | ZA200205830B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7790178B2 (en) | 2002-12-19 | 2010-09-07 | Intervet International B.V. | Trivalent vaccine with maternal anitbody transfer via the milk |
| CA2596920C (en) * | 2005-01-28 | 2015-05-05 | North-West University | Lipid and nitrous oxide combination as adjuvant for the enhancement of the efficacy of vaccines |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| AU532186B2 (en) | 1978-07-21 | 1983-09-22 | Merck & Co., Inc. | Herpes virus vaccine |
| AU626271B2 (en) * | 1987-11-03 | 1992-07-30 | Syntex (U.S.A.) Inc. | Vaccine adjuvant |
| US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
| JPH11106351A (ja) * | 1997-10-02 | 1999-04-20 | Chemo Sero Therapeut Res Inst | オイルアジュバントワクチンおよびその製造方法 |
| US6093564A (en) * | 1997-10-03 | 2000-07-25 | V.I. Technologies, Inc. | Methods and compositions for the selective modification of nucleic acids |
| GB9726555D0 (en) * | 1997-12-16 | 1998-02-11 | Smithkline Beecham Plc | Vaccine |
| FR2775601B1 (fr) * | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
| FR2776928B1 (fr) * | 1998-04-03 | 2000-06-23 | Merial Sas | Vaccins adn adjuves |
-
2000
- 2000-01-21 FR FR0000797A patent/FR2804026B1/fr not_active Expired - Lifetime
-
2001
- 2001-01-19 MX MXPA02007115A patent/MXPA02007115A/es active IP Right Grant
- 2001-01-19 AT AT01905858T patent/ATE540693T1/de active
- 2001-01-19 HU HU0203831A patent/HU228703B1/hu unknown
- 2001-01-19 EP EP01905858A patent/EP1248648B1/de not_active Expired - Lifetime
- 2001-01-19 AU AU33831/01A patent/AU782657C/en not_active Expired
- 2001-01-19 JP JP2001552934A patent/JP2003520249A/ja active Pending
- 2001-01-19 CA CA2397861A patent/CA2397861C/en not_active Expired - Lifetime
- 2001-01-19 NZ NZ520242A patent/NZ520242A/en not_active IP Right Cessation
- 2001-01-19 BR BRPI0107771-6A patent/BRPI0107771B1/pt unknown
- 2001-01-19 PL PL356556A patent/PL209070B1/pl unknown
- 2001-01-19 WO PCT/FR2001/000189 patent/WO2001052887A2/fr not_active Ceased
- 2001-01-19 BR BR0107771-6A patent/BR0107771A/pt active IP Right Grant
-
2002
- 2002-07-22 ZA ZA200205830A patent/ZA200205830B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003520249A (ja) | 2003-07-02 |
| EP1248648A2 (de) | 2002-10-16 |
| MXPA02007115A (es) | 2003-01-28 |
| PL356556A1 (en) | 2004-06-28 |
| HUP0203831A3 (en) | 2004-07-28 |
| PL209070B1 (pl) | 2011-07-29 |
| BRPI0107771B1 (pt) | 2017-06-13 |
| FR2804026B1 (fr) | 2004-06-11 |
| AU782657B2 (en) | 2005-08-18 |
| CA2397861C (en) | 2017-04-04 |
| EP1248648B1 (de) | 2012-01-11 |
| AU782657C (en) | 2006-07-13 |
| WO2001052887A3 (fr) | 2002-01-31 |
| BR0107771A (pt) | 2002-11-12 |
| WO2001052887A2 (fr) | 2001-07-26 |
| AU3383101A (en) | 2001-07-31 |
| ZA200205830B (en) | 2003-09-29 |
| NZ520242A (en) | 2004-06-25 |
| HU228703B1 (en) | 2013-05-28 |
| HUP0203831A2 (hu) | 2003-03-28 |
| CA2397861A1 (en) | 2001-07-26 |
| FR2804026A1 (fr) | 2001-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015073D0 (no) | Vaksiner | |
| IL150602A (en) | Proteosome influenza vaccine, method for preparing such and use thereof | |
| Babiuk et al. | Immunization of animals: from DNA to the dinner plate | |
| DE60012042D1 (de) | Entepneumovirus und entsprechendes impfstoff | |
| DE60039198D1 (de) | Adjuvanszusammensetzungen zur Erhöhung der Immunantwort bezüglich Polynukleotid-basierenden Impfstoffen | |
| WO2007022151A3 (en) | Immunization of avians by administration of non-replicating vectored vaccines | |
| RU2013119946A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| SG163598A1 (en) | Lawsonia vaccine and methods of use thereof | |
| EP1471936A4 (de) | Hiv-vakzine und anwendungsverfahren | |
| CY1112575T1 (el) | Βελτιωμενα αδρανοποιημενα εμβολια fcv | |
| DE60136928D1 (de) | Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme | |
| ATE310008T1 (de) | Immunologische adjuvans verbindungen | |
| Gonzalez et al. | Evaluation of a bovine rotavirus VP6 vaccine efficacy in the calf model of infection and disease | |
| AU782657C (en) | Vaccination against canine herpesvirus infection and vaccines | |
| NO20020615D0 (no) | Vaksine | |
| MX2022007217A (es) | Vacuna epitópica para virus de fiebre porcina africana. | |
| TN2014000393A1 (en) | Modified marek's disease virus, and vaccines made therefrom | |
| RU2010143584A (ru) | Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят | |
| WO2004100640A3 (en) | Marek’s disease virus vaccine | |
| PT1194450E (pt) | Vacina inactivada contra a calicivirose felina | |
| AU2003294192A8 (en) | Inclusion bodies as antigens for the oral vaccination of animals | |
| WO2004043286A3 (en) | Use of rmlt as a marker antigen for vaccines and as a synergistic adjuvant with amphigen | |
| Lelešius et al. | The impact of different adjuvants upon vaccinal induction of secondary immune response against porcine parvovirus |